Medicine and Dentistry
Breast Cancer
97%
Triple Negative Breast Cancer
78%
Neoplasm
54%
Biological Marker
43%
BRCA1
41%
Diseases
39%
Therapeutic Procedure
37%
Patient
37%
Malignant Neoplasm
36%
Combination Therapy
33%
Breast
31%
Cells
31%
Prostate Cancer
29%
microRNA
29%
Personalized Medicine
21%
Radiation Therapy
20%
DNA Damage
19%
Low Drug Dose
19%
Carcinogenicity
19%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
19%
Immunity
19%
DNA
16%
In Vitro
14%
Serous Carcinoma
13%
Ovarian Cancer
13%
Digital Pathology
13%
Assessment
13%
Mutant
13%
Differentiation
12%
Estrogen Receptor
12%
Immune Response
12%
Protein
11%
Association
11%
Messenger RNA
11%
Peptide
11%
Stem Cell
11%
Lesion
11%
Development
11%
Prognosis
10%
Targeted Therapy
10%
Antibody
10%
cGAS-STING signaling pathway
10%
Microarray
10%
Nucleic Acid
9%
Implant
9%
Cancer Treatment
9%
Cathepsin S
9%
DNA Damage Response
9%
Intraductal Carcinoma
9%
COVID-19 Vaccine
9%
Biochemistry, Genetics and Molecular Biology
BRCA1
100%
Cancer Cell
56%
Drive
41%
Nested Gene
39%
Protein
37%
Mutant
33%
Growth
31%
MicroRNA
29%
Phenotype
27%
Promoter Region
23%
DNA
23%
Tumor Suppressor Gene
21%
Radiation
20%
GATA3
19%
Anthracycline
19%
Immunity
19%
Low Drug Dose
19%
Regulatory Mechanism
16%
Sample
15%
Peptide
14%
Development
14%
Defense Mechanism
14%
Upregulation
13%
Association
12%
Estrogen Receptor
12%
Clone
12%
NDRG1
11%
Overall Survival
11%
Kinase
11%
P53
10%
Survival Factor
10%
Dose
10%
Histone Deacetylase
9%
S100A2
9%
Heterochromatin Protein 1
9%
Glucocorticoid Receptor
9%
NUP98
9%
Cathepsin S
9%
Digital Pathology
9%
LYN
9%
Thromboxane A2
9%
Methylation
9%
N-Myc
9%
Dispersity
9%
Cathepsin
9%
FOXA1
9%
Cell-Penetrating Peptide
9%
Germline Mutation
9%
Evolution
9%
Liquid
9%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
72%
Triple Negative Breast Cancer
60%
Chemotherapy
46%
DNA
31%
microRNA
29%
Diseases
28%
Malignant Neoplasm
26%
Anthracycline
24%
Peptide
21%
Glucocorticoid Receptor
19%
Carcinogenicity
19%
Nanoparticle
16%
Trastuzumab
13%
Taxane
12%
Biological Marker
12%
Prostate Cancer
11%
Apoptosis
11%
Cathepsin V
9%
Fusobacterium nucleatum
9%
Cardiotoxicity
9%
Gamma Interferon
9%
Alendronic Acid
9%
Glioblastoma
9%
Pharmacology
9%
Nitrogen
9%
Bisphosphonic Acid Derivative
9%
Synthetase
9%
Gene Delivery
9%
Nanomedicine
9%
Cell Penetrating Peptide
9%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
9%
Antigen
9%
Transcription Factor GATA 3
9%
Clinical Research
9%
Messenger RNA
9%
Androgen Receptor
9%
Bisphosphonic Acid Derivative
9%
Breast Cancer
9%
Colorectal Carcinoma
9%
Prodrug
9%
Neoplasm
9%
Side Effect
8%
Breast Tumor
7%
Neoplasm
7%
Dexamethasone
6%
Mouse
6%
Solid Lipid Nanoparticle
6%
Antibody
6%
Deoxyuridine Triphosphate Pyrophosphatase
6%
Survival
6%